Top-News
Pharmazeutika USA

Supernus Pharmaceuticals News

Aktie
WKN:  A1JX3U ISIN:  US8684591089 US-Symbol:  SUPN
28,60 €
+0,20 €
+0,70%
29.04.24 15:37:59
Handeln Depot/Watchlist
Aktienanzahl *
54,63 Mio.
Marktkapitalisierung *
1,53 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 22.02.2024

Supernus Pharmaceuticals News

28.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
20.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
05.03.24 - PR Newswire
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies?
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies? PR Newswire
04.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
26.10.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
19.10.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
02.05.22 - PR Newswire
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults PR Newswire
02.11.21 - PR Newswire
ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS
ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
13.10.21 - PR Newswire
Thinking about buying stock in DatChat, Infosys, Supernus Pharmaceuticals, FuelCell Energy, or Ocugen?
Thinking about buying stock in DatChat, Infosys, Supernus Pharmaceuticals, FuelCell Energy, or Ocugen? PR Newswire
11.10.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Adamas Pharmaceuticals, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Adamas Pharmaceuticals, Inc. PR Newswire
17.06.21 - PR Newswire
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics? PR Newswire
13.04.21 - PR Newswire
Thinking about buying stock in IZEA Worldwide, WiMi Hologram Cloud, Veru, iHeartMedia, or Supernus Pharmaceuticals?
Thinking about buying stock in IZEA Worldwide, WiMi Hologram Cloud, Veru, iHeartMedia, or Supernus Pharmaceuticals? PR Newswire
05.04.21 - PR Newswire
Thinking about trading options or stock in Invitae Corp, Tesla, Supernus Pharmaceuticals, Mohawk Group, or WW International?
Thinking about trading options or stock in Invitae Corp, Tesla, Supernus Pharmaceuticals, Mohawk Group, or WW International? PR Newswire
23.12.20 - PR Newswire
Thinking about buying stock in Ocugen, Kopin Corp, Mogo Inc, Supernus Pharmaceuticals, or eMagin Corp?
Thinking about buying stock in Ocugen, Kopin Corp, Mogo Inc, Supernus Pharmaceuticals, or eMagin Corp? PR Newswire
11.11.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
01.06.18 - PR Newswire
Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders
Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders PR Newswire
19.09.16 - PR Newswire
Learn how to target a 20% return on Netflix, or get option-trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose
Learn how to target a 20% return on Netflix, or get option-​trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose PR Newswire
12.07.16 - PR Newswire
Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors
Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors PR Newswire
09.02.16 - PR Newswire
Covered Call Alerts For Starbucks, GW Pharmaceuticals, Supernus Pharmaceuticals, CSX and SunEdison Released By InvestorsObserver
Covered Call Alerts For Starbucks, GW Pharmaceuticals, Supernus Pharmaceuticals, CSX and SunEdison Released By InvestorsObserver PR Newswire
24.09.15 - The Motley Fool
Die am schnellsten wachsenden Biotechaktien
Selbst nach der ersten Korrektur seit vier Jahren lassen Biotechaktien den S&P 500 weit hinter sich. Der börsengehandelte Fonds SPDR S&P Biotech hat in den letzten fünf Jahren ...

Newssuche

Videos

newspaper
08:35 Uhr -14,29%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »